Opportunity Information: Apply for PA 15 188
Apply for PA 15 188
- The National Institutes of Health in the education health income security and social services sector is offering a public funding opportunity titled "Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.393 Cancer Cause and Prevention Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.865 Child Health and Human Development Extramural Research 93.866 Aging Research.
- This funding opportunity was created on Apr 28, 2015 and posted on Apr 28, 2015.
- Applicants must submit their applications by Sep 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Small businesses Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Native American tribal governments (Federally recognized) State governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01) is an NIH research grant opportunity (Funding Opportunity Number PA 15 188) focused on advancing pain treatments by studying cannabinoids and the body s own endocannabinoid system. The main goal is to fund mechanistic, hypothesis driven projects that clarify how cannabinoid related pathways influence pain signaling and pain modulation, with the larger intent of translating that knowledge into mechanism based therapies. In practice, this means the FOA is aimed at research that can explain what is happening biologically (for example, which receptors, signaling pathways, cell types, or neural circuits are involved) and how those findings can be leveraged to develop or refine therapeutic strategies for pain conditions.
The opportunity uses the R01 mechanism, which is NIH s standard grant program for investigator initiated research projects and typically supports well developed research plans that can be carried out over multiple years. It is categorized as a discretionary grant funding instrument, and it falls under broad public purpose areas that include education, health, and social services. The announcement ties to multiple NIH related CFDA program areas, reflecting the cross cutting nature of pain research and cannabinoid biology. Those CFDA numbers include complementary and integrative health research (93.213), alcohol research (93.273), drug abuse and addiction research (93.279), cancer cause and prevention research (93.393), neurosciences and neurological disorders extramural research (93.853), child health and human development research (93.865), and aging research (93.866). Taken together, that list signals that NIH viewed endocannabinoid based pain research as relevant to many disease areas and populations, including conditions where pain intersects with cancer, substance use, neurological disorders, development across the lifespan, and aging.
A notable feature of this FOA is its broad eligibility. Applicants could come from many organization types, including public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for profit organizations (including small businesses), and a wide range of government entities such as state, county, city or township governments, independent school districts, special district governments, and public or Indian housing authorities. The eligibility language also explicitly includes tribal governments and tribal organizations, as well as a variety of mission focused institution types such as Historically Black Colleges and Universities, Hispanic Serving Institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions. In addition, it allows certain non U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, eligible federal agencies, and faith based or community based organizations, which indicates an intent to encourage participation from diverse research settings and communities.
From an administrative standpoint, the FOA did not require cost sharing or matching, which generally lowers barriers for applicants by not requiring them to contribute non federal funds to the project budget. The announcement was posted and created on April 28, 2015, with an original and final closing date of September 7, 2018, and it was archived on October 8, 2018. That timeline means it was a time limited NIH program announcement that accepted applications through that final due date window.
The sponsoring agency is the National Institutes of Health. The FOA emphasizes understanding therapeutic potential, which typically implies research that can identify promising molecular targets, validate mechanisms in relevant models, and establish the rationale for future intervention development. While the brief description does not list specific required topics, the framing around cannabinoids and the endocannabinoid system suggests projects could involve cannabinoid receptors and related signaling, endogenous cannabinoid ligands and their synthesis or breakdown, and how manipulating these components changes pain processing. The phrase mechanism based therapies is important because it implies NIH was looking for more than descriptive studies; it points toward work that can link biological mechanism to potential treatment approaches in a way that could eventually support translational development.
For further details, NIH provided an official link to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PA-15-188.html. For access or technical issues with the electronic posting, the contact listed is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV, including support for difficulties accessing the announcement or problems linking to it.
Frequently Asked Questions (FAQs)
What is the title of this NIH grant opportunity?
The opportunity is titled Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PA-15-188.
What agency is sponsoring this funding opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What type of grant mechanism does this opportunity use?
This FOA uses the R01 mechanism, NIH's standard grant program for investigator-initiated research projects. It generally supports well-developed research plans conducted over multiple years.
What is the main goal of PA-15-188?
The main goal is to fund mechanistic, hypothesis-driven research that clarifies how cannabinoid-related pathways influence pain signaling and pain modulation, with the broader intent of translating that knowledge into mechanism-based therapies for pain conditions.
What does "mechanistic, hypothesis-driven" mean in the context of this FOA?
In this FOA, "mechanistic, hypothesis-driven" refers to projects designed to explain what is happening biologically and why (for example, identifying which receptors, signaling pathways, cell types, or neural circuits are involved), rather than only describing observations. The intent is to connect biological mechanisms to therapeutic strategies for pain.
What kinds of research topics are suggested by the FOA description?
While specific required topics are not listed in the provided summary, the framing indicates projects may involve:
- Cannabinoid receptors and related signaling
- Endogenous cannabinoid ligands and their synthesis or breakdown
- How manipulating components of the endocannabinoid system changes pain processing
- Mechanistic work linking pathways to potential therapeutic approaches
What is meant by "mechanism-based therapies" in this opportunity?
"Mechanism-based therapies" implies research that links specific biological mechanisms in the endocannabinoid system to potential treatment approaches, supporting eventual translation into interventions grounded in validated mechanisms rather than purely descriptive findings.
What broad public purpose areas does this opportunity fall under?
The opportunity falls under broad public purpose areas including education, health, and social services.
Which CFDA program areas are associated with this announcement?
The announcement ties to multiple NIH-related CFDA program areas, including:
- 93.213 - Complementary and integrative health research
- 93.273 - Alcohol research
- 93.279 - Drug abuse and addiction research
- 93.393 - Cancer cause and prevention research
- 93.853 - Neurosciences and neurological disorders extramural research
- 93.865 - Child health and human development research
- 93.866 - Aging research
What does the range of CFDA program areas suggest about the FOA?
The spread of CFDA areas suggests NIH viewed endocannabinoid-based pain research as cross-cutting and relevant to many disease areas and populations, including intersections with cancer, substance use, neurological disorders, development across the lifespan, and aging.
Who is eligible to apply for this funding opportunity?
Eligibility is described as broad. Applicants may include many organization types such as:
- Public and private institutions of higher education
- Nonprofits (with or without 501(c)(3) status)
- For-profit organizations (including small businesses)
- Government entities (state, county, city or township governments)
- Independent school districts
- Special district governments
- Public or Indian housing authorities
- Tribal governments and tribal organizations
- U.S. territories or possessions
- Eligible federal agencies
- Faith-based or community-based organizations
- Certain non-U.S. entities (foreign organizations) and regional organizations
Are minority-serving institutions explicitly included in the eligibility language?
Yes. The eligibility language explicitly includes institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions (HSIs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions.
Does this FOA allow applications from non-U.S. organizations?
Yes. The eligibility description includes certain non-U.S. entities (foreign organizations) as well as regional organizations.
Is cost sharing or matching required?
No. The FOA did not require cost sharing or matching.
When was this funding opportunity posted and created?
The announcement was posted and created on April 28, 2015.
What were the original and final closing dates for applications?
The original and final closing date listed is September 7, 2018.
When was the FOA archived?
The FOA was archived on October 8, 2018.
Is this opportunity still open?
Based on the provided timeline (final closing date September 7, 2018 and archived October 8, 2018), this FOA is described as time-limited and is not presented as currently open in the summary provided.
Where can applicants find the official NIH announcement?
The official announcement is available at: http://grants.nih.gov/grants/guide/pa-files/PA-15-188.html
Who should be contacted for access or technical issues with the electronic posting?
For difficulties accessing the announcement or problems linking to it, the listed contact is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
What is the funding instrument type for this opportunity?
The opportunity is categorized as a discretionary grant funding instrument.
What is the bigger translational intent behind the research funded under this FOA?
The larger intent is to use mechanistic insights about cannabinoids and the endocannabinoid system to support the development or refinement of therapeutic strategies for pain, grounded in clearly defined biological mechanisms.
Browse more opportunities from the same category: Education Health Income Security and Social Services
Next opportunity: Conservation Innovation Grant (CIG) FY15
Previous opportunity: DoD Multiple Sclerosis Pilot Clinical Trial Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 188
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 188) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Health of Sexual and Gender Minority (SGM) Populations (R21) Apply for PA 15 263 Funding Number: PA 15 263 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| The Health of Sexual and Gender Minority (SGM) Populations (R03) Apply for PA 15 262 Funding Number: PA 15 262 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $50,000 |
| The Health of Sexual and Gender Minority (SGM) Populations (R15) Apply for PA 15 260 Funding Number: PA 15 260 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| The Health of Sexual and Gender Minority (SGM) Populations (R01) Apply for PA 15 261 Funding Number: PA 15 261 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Pre application Opportunities for Collaborative Research at the NIH Clinical Center (X02) Apply for PAR 15 286 Funding Number: PAR 15 286 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Theories, Models and Methods for Analysis of Complex Data from the Brain (R01) Apply for RFA EB 15 006 Funding Number: RFA EB 15 006 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| End of Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01) Apply for PA 15 324 Funding Number: PA 15 324 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| End of Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21) Apply for PA 15 325 Funding Number: PA 15 325 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) Apply for PA 15 329 Funding Number: PA 15 329 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $100,000 |
| BRAIN Initiative Technology Sharing and Propagation (R03) Apply for RFA MH 16 725 Funding Number: RFA MH 16 725 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $100,000 |
| BRAIN Initiative Short Courses in Computational Neuroscience (R25) Apply for RFA MH 16 700 Funding Number: RFA MH 16 700 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Research on Emergency Medical Services for Children (R01) Apply for PAR 08 261 Funding Number: PAR 08 261 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Research on Integrity in Collaborative Research (R21) Apply for RFA RR 09 004 Funding Number: RFA RR 09 004 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32) Apply for PAR 08 101 Funding Number: PAR 08 101 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) Apply for PAR 08 155 Funding Number: PAR 08 155 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $275,000 |
| Millennium Promise Awards Non communicable Chronic Diseases Research Training Program (NCoD) (D43) Apply for PAR 08 175 Funding Number: PAR 08 175 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) Apply for PA 08 226 Funding Number: PA 08 226 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Research on Social Work Practice and Concepts in Health (R03) Apply for PA 06 233 Funding Number: PA 06 233 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $50,000 |
| Research on Social Work Practice and Concepts in Health (R21) Apply for PA 06 234 Funding Number: PA 06 234 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Neurotechnology Research, Development, and Enhancement (R21) Apply for PA 06 278 Funding Number: PA 06 278 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 188", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
